Investor Relations

Chairman and Chief Executive Officer, Edwards Lifesciences. Mr. Mussallem, age 55, has been a director of the Company since 2000. Mr. Mussallem is Chairman of the Board and Chief Executive Officer of the Company. Prior to 2000, he held a variety of positions with increasing responsibility in engineering, product development and senior management at Baxter International Inc. including Group Vice President of the CardioVascular business from 1994 to 2000 and Group Vice President of the Biopharmaceutical business from 1998 to 2000. From 1996 until 1998, he was the Chairman of Baxter's Asia Board overseeing Baxter's operations throughout Asia. Mr. Mussallem received his Bachelor of Science degree in chemical engineering from Rose-Hulman Institute of Technology and was conferred an honorary doctorate by his alma mater in 1999. Mr. Mussallem is chairman of the board of directors of the Advanced Medical Technology Association (AdvaMed), and serves as a member of the board for Advanced Medical Optics, Inc. He is also on the boards and executive committees of the California Healthcare Institute and OCTANe, and is a member of the University of California, Irvine, Chief Executive Roundtable.

Retired, Former Partner, Deloitte & Touche. Mr. Cardis, age 66, was appointed as a director by the Board in June 2004. Mr. Cardis, formerly a partner of Deloitte & Touche, has 40 years of experience in finance, accounting and governance. While at Deloitte & Touche, Cardis was National Managing Partner-Global Strategic Clients, responsible for overseeing and directing services to many of the firm’s largest clients. He also served on Deloitte & Touche’s executive committee for 15 years and on its board of directors for eight years, and helped guide the firm and its clients through the new challenges brought about by the Sarbanes-Oxley Act and the changing governance environment. Mr. Cardis remains actively involved in a number of non-profit and community organizations including Los Angeles Business Advisors and Marian College, and was chairman, United Way of Greater Los Angeles, and chairman, Boy Scouts of America.

Professor and Chair, Department of Health Care Policy, Harvard Medical School and Professor of Radiology, Harvard Medical School and Brigham and Women's Hospital. Dr. McNeil, age 66, was elected to the Board of Directors for the Company in February, 2006. Dr. McNeil is Professor and Chair of the Department of Health Care Policy at Harvard Medical School and Professor of Radiology at both Harvard Medical School and Brigham and Women's Hospital in Boston, Massachusetts. She received her M.D. from Harvard Medical School, and her Ph.D. in Biological Chemistry from Harvard University. She is a member of the Institute of Medicine of the National Academy of Sciences, where she chairs its Board of Health Care Services. Dr. McNeil also holds memberships in the American Academy of Arts and Sciences and the Council for Performance Measurement for the Joint Commission on Accreditation of Healthcare Organizations.

Chairman, Chief Executive Officer and President, Allergan, Inc. Mr. Pyott, age 54, has been a director of the Company since 2000. Mr. Pyott is Chairman of the Board, Chief Executive Officer and President of Allergan, Inc., a technology driven, global health care company providing eye care and specialty pharmaceutical products worldwide. Prior to joining Allergan in 1998, he was a division president and a member of the executive committee of Novartis AG, and before 1996 he held various positions with Sandoz International AG and Sandoz Nutrition Corporation. In addition to being a director of Allergan, Inc., he is a director of Avery Dennison Corporation, Pacific Mutual Holding Company and Pacific LifeCorp. He also serves on the Board and Executive Committee of the California Healthcare Institute and is on the Directors' Board of the University of California (Irvine), Graduate School of Management.

Retired, Former Chairman, Atlantic Richfield Company. Mr. Bowlin, age 64, has been a director of the Company since 2000. Mr. Bowlin served as Chairman of the Board of Atlantic Richfield Company from 1995 to 2000. He also served as its President from 1993 to 1998, and as its Chief Executive Officer from 1994 to 2000. Atlantic Richfield Company and its subsidiaries, which merged with BP Amoco in 2000, were engaged in the worldwide exploration, development, production, transportation and refining of petroleum and natural gas. Mr. Bowlin also is a director of FMC Technologies, Inc. and Horizon Health Corporation. Mr. Bowlin is a director of the University of North Texas Foundation, and is a member of the M.D. Anderson Cancer Center Board of Visitors.

Vice Chairman of Pharmaceutical Operations, GlaxoSmithKline plc. Mr. Ingram, age 65, has been a director since February 2003. He currently serves as Vice Chairman Pharmaceutical Operations, GlaxoSmithKline plc, a corporation involved in the research, development, manufacturing and sale of pharmaceuticals. Mr. Ingram served as the Chief Operating Officer and President of Pharmaceutical Operations, GlaxoSmithKline plc from January 2001 until his retirement in December 2002. Prior to that, he was Chief Executive Officer of Glaxo Wellcome plc from 1997 to 2000, and Chairman of Glaxo Wellcome Inc., Glaxo Wellcome plc's United States subsidiary, from January 1999 to December 2000. From 1997 to 1999, Mr. Ingram served as Chairman and President of Glaxo Wellcome plc. Mr. Ingram is also a director of Wachovia Corporation, Nortel Networks Corporation, Lowe's Companies, Inc., OSI Pharmaceuticals, Inc., Allergan, Inc. and Valeant Pharmaceuticals International.

Former Chairman and Chief Executive Officer, Avery Dennison Corporation. Mr. Neal, age 67, has been a director of the Company since 2000. Mr. Neal served as Chairman of the Board and Chief Executive Officer of Avery Dennison Corporation, a Fortune 500 company that manufactures and markets a wide range of products for consumer and industrial markets, including Avery brand office supplies and Fasson brand self-adhesive materials. Mr. Neal joined Avery Dennison in 1974, and served as President and Chief Operating Officer from 1990 to 1998. He was elected Chief Executive Officer in 1998 and appointed Chairman in 2000. Mr. Neal also serves as a director of the Los Angeles Music Center, a trustee of Pomona College and the California Institute of Technology, and a member of the Board of Governors of Town Hall of California, California Business Roundtable.